Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Introduction of AVT05 supported by NHS England tender award in the United KingdomREYKJAVIK, ICELAND (December 22, 2025) - ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

In 2025, the latest biosimilar policy developments included bipartisan efforts to enhance affordability and reduce barriers ...

Investing.com -- JPMorgan outlined four major large-cap U.S. pharmaceutical stocks it sees performing well in 2026 amid positive regulatory developments and a healthy drug pipeline. JPMorgan said it ...